SCM
SZYM

Stevens Capital Management’s SOLAZYME INC COM STK (DE) SZYM Stock Holding History

Stevens Capital Management’s Portfolio SZYM Stock Details SZYM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-29,132
Closed -$75K – 1399
2014
Q4 		$75K Buy
+29,132
New +$127K ﹤0.01% 944
2014
Q2 		– Sell
-10,954
Closed -$127K – 1460
2014
Q1 		$127K Buy
+10,954
New +$129K ﹤0.01% 989

Other funds holding SZYM

Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
PC
Passport Capital San Francisco, California $394M AUM 50.67% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
UCFA
United Capital Financial Advisors Irving, Texas $16.3B AUM 16.34% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Lazard Asset Management
Lazard Asset Management New York $60.8B AUM 22.47% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Stevens Capital Management's SZYM Position: Q1 2015 in Review

Stevens Capital Management sold out of SOLAZYME INC COM STK (DE) (SZYM) in Q1 2015, closing a stake of 29,132 shares — an estimated $75K sold.

Stevens Capital Management first reported a position in SZYM in Q1 2014 and held it in 2 quarters. The position peaked at $127K in Q1 2014. 102 funds tracked by Wall St. Rank hold SZYM as of Q1 2015.

  • Stevens Capital Management reported no remaining SOLAZYME INC COM STK (DE) position as of Q1 2015 after selling out during the quarter.
  • Stevens Capital Management sold 29,132 SOLAZYME INC COM STK (DE) shares in Q1 2015, an estimated $75K.
  • Stevens Capital Management first reported a position in SOLAZYME INC COM STK (DE) in Q1 2014 and held it in 2 quarters.
  • Stevens Capital Management's SOLAZYME INC COM STK (DE) position peaked at $127K in Q1 2014.
  • 102 funds tracked by Wall St. Rank held SOLAZYME INC COM STK (DE) as of Q1 2015.

Based on Stevens Capital Management's 13F filing for Q1 2015, filed 7 May 2015.